ESTIMATED
06/27/2024
06/27/2024
(AS OF MARCH 31)
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 3 | $0.79 | $0.84 | $0.82 |
Q2 2024 | 6 | $0.65 | $0.70 | $0.68 |
Q3 2024 | 9 | $0.35 | $0.46 | $0.42 |
Q4 2024 | 3 | $0.50 | $0.53 | $0.52 |
Q1 2025 | 4 | $0.64 | $0.68 | $0.66 |
Q2 2025 | 8 | $0.55 | $0.59 | $0.57 |
Q3 2025 | 4 | $0.42 | $0.45 | $0.43 |
Q4 2025 | 5 | $0.61 | $0.65 | $0.63 |
Q1 2026 | 3 | $0.74 | $0.79 | $0.77 |
Q2 2026 | 3 | $0.60 | $0.64 | $0.63 |
Q3 2026 | 3 | $0.51 | $0.55 | $0.53 |
Walgreens Boots Alliance, Inc. last posted its earnings results on Thursday, June 27th, 2024. The company reported $0.63 earnings per share for the quarter, missing analysts' consensus estimates of $0.681 by $0.051. The company had revenue of 36.35 B for the quarter and had revenue of 139.08 B for the year. Walgreens Boots Alliance, Inc. has generated $-4 earnings per share over the last year ($-3.57 diluted earnings per share) and currently has a price-to-earnings ratio of -1.72. Walgreens Boots Alliance, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, June 26th, 2024 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 06/27/2024 | Q3 2024 | $0.68 | $0.40 | -0.28 | $35.94 B | $36.35 B | 03/28/2024 | Q2 2024 | $0.82 | -$6.85 | -7.67 | $37.05 B | 01/04/2024 | Q1 2024 | $0.63 | -$0.08 | -0.71 | $36.71 B | 10/12/2023 | Q4 2023 | $0.68 | -$0.21 | -0.89 | $34.80 B | $35.42 B | 06/27/2023 | Q3 2023 | $1.06 | -$0.06 | -1.12 | $34.26 B | $35.42 B | 03/28/2023 | Q2 2023 | $1.10 | $0.62 | -0.48 | $34.86 B | 01/05/2023 | Q1 2023 | $1.15 | -$4.43 | -5.58 | $33.38 B | 10/13/2022 | Q4 2022 | $0.78 | -$0.61 | -1.39 | $32.09 B | $32.45 B | 06/30/2022 | Q3 2022 | $0.95 | $0.33 | -0.62 | $37.13 B | $32.60 B | 03/31/2022 | Q2 2022 | $1.39 | $1.02 | -0.37 | $33.76 B | 01/06/2022 | Q1 2022 | $1.35 | $4.13 | 2.78 | $33.90 B | 10/14/2021 | Q4 2021 | $1.03 | $0.72 | -0.31 | $34.26 B | 07/01/2021 | Q3 2021 | $1.17 | $1.38 | 0.21 | $34.03 B | 03/31/2021 | Q2 2021 | $1.11 | $1.19 | 0.08 | $32.78 B | 01/07/2021 | Q1 2021 | $1.02 | -$0.36 | -1.38 | $31.44 B | 10/15/2020 | Q4 2020 | $0.96 | $0.43 | -0.53 | $34.75 B | 07/09/2020 | Q3 2020 | $1.10 | -$1.95 | -3.05 | $34.63 B | 04/02/2020 | Q2 2020 | $1.45 | $1.07 | -0.38 | $35.27 B | $35.82 B | 01/08/2020 | Q1 2020 | $1.40 | $0.95 | -0.45 | $34.34 B | 10/28/2019 | Q4 2019 | $1.41 | $0.75 | -0.66 | $33.95 B |
---|
A. Walgreens Boots Alliance, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, June 26th, 2024 based off last year's report dates.
A. The conference call for Walgreens Boots Alliance, Inc.'s latest earnings report can be listened to online.
A. The conference call transcript for Walgreens Boots Alliance, Inc.'s latest earnings report can be read online.
A. Walgreens Boots Alliance, Inc. (NASDAQ:WBA) has a recorded annual revenue of $139.08 B.
A. Walgreens Boots Alliance, Inc. (NASDAQ:WBA) has a recorded net income of $139.08 B. Walgreens Boots Alliance, Inc. has generated $-3.57 earnings per share over the last four quarters.
A. Walgreens Boots Alliance, Inc. (NASDAQ:WBA) has a price-to-earnings ratio of -1.72 and price/earnings-to-growth ratio is -3.68.